Supplier Type
- Trader
- Manufacturer
- custom synthesis
- Reagent
Supplier Region
- Mumbai(45)
- New Delhi(3)
- Gujarat(22)
- Bangalore(1)
- Hyderabad(9)
- Vadodara(7)
- Haryana(10)
- Delhi(9)
- Madhya Pradesh(3)
- Nagpur(7)
- Maharashtra(4)
- Pune(2)
- Ahmedabad(12)
- Uttar Pradesh(3)
- Punjab(4)
- Andhra Pradesh(1)
Purity
- NLT 95%
- NLT 90%
- Heat resistant injection stage
- good
- API Standards
- API Impurity / In-house working standard
- 99.74%
- 99%
- >99%
- > 98%
- 98%
- >98%
- 97%
- 96%
- >95%
- 94.80%
- >92%
- 92%
- >90%
- 90%
- 90 % Above
- 85%
- 70%
- 25 MG 50 MG 100 MG 250 MG EXTRA
- 1.2M
Package
- 50mg
- 2.5501e+00925 MG 50 MG 100 MG 250 MG EXTRA
- 0MG TO GRAM
- 25mg
- 100mg
- 250mg
- 500mg
- 1gm
- 100ml
- 500ml
- 1kg
- 1L
- 5kg
- 10kg
- 25kg
- 100kg
- 1MT
- 25kgs
- 95NLT %
- 300grams
- 250250 mg.
-
Chlorogenic acid
327-97-9
-
ISOPROPYL TRIFLUOROACETATE
400-38-4
-
2-(Trifluoromethyl)-1-iodo-4-nitrobenzene
400-75-9
-
1-Hydroxyibuprofen
53949-53-4
-
4-(4-CYANOBENZYL)-1,2,4-TRIAZOLE
112809-27-5
-
3-Oxopregn-4-ene-20-carbaldehyde
24254-01-1
-
6-broMo-8-cyclopentyl-5-Methyl-2-(5-(piperazin-1-yl)pyridin-2-ylaMino)pyrido[2,3-d]pyriMidin-7(8H)-one
851067-56-6
-
N-Deethyl DorzolaMide Hydrochloride
164455-27-0
-
1-Naphthol
90-15-3
-
Linagliptin Impurity S
668273-74-3
Isopropyl Trifluoroacetate 400-38-4
1-Iodo-4-nitro-2- (trifluoromethyl)benzene 400-75-9
IBUPROFEN IMPURITY L 53949-53-4
Carvedilol EP Impurity B 918903-20-5
Vaxiflu-4 Allopathic 4mg Vaxiflu Injection, Packaging Type: Box, 0.5 ml
